Potentially repurposing adamantanes for COVID-19
- PMID: 32176361
- DOI: 10.1002/jmv.25752
Potentially repurposing adamantanes for COVID-19
Comment in
-
A retrospective review of memantine use and COVID-19-associated mortality from a national database.J Med Virol. 2021 Jan;93(1):168-169. doi: 10.1002/jmv.26266. Epub 2020 Jul 14. J Med Virol. 2021. PMID: 32633865 Free PMC article. No abstract available.
Comment on
-
Clinical trial analysis of 2019-nCoV therapy registered in China.J Med Virol. 2020 Jun;92(6):540-545. doi: 10.1002/jmv.25733. Epub 2020 Mar 5. J Med Virol. 2020. PMID: 32108352 Free PMC article. Review.
References
REFERENCES
-
- Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China [published online ahead of print February 28, 2020]. J Med Virol. 2020. https://doi.org/10.1002/jmv.25733
-
- Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [published online ahead of print February 19, 2020]. Biosci Trends. 2020. https://doi.org/10.5582/bst.2020.01047
-
- Payne HR, Storz J, Henk WG. Initial events in bovine coronavirus infection: analysis through immunogold probes and lysomotropic inhibitors. Arch Virol. 1990;114(3-4):175-189.
-
- Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323(1):264-268.
-
- Takano T, Katoh Y, Doki T, Hohdatsu T. Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo. Antiviral Res. 2013;99(2):100-107.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
